WVP
TGAN icon

Worth Venture Partners’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Worth Venture Partners’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,153,778
Closed -$4.21M – 130
2023
Q4 		$4.21M Buy
1,153,778
+1,500
+0.1% +$4.11K 2.28% 11
2023
Q3 		$2.56M Buy
1,152,278
+50,598
+5% +$141K 1.52% 15
2023
Q2 		$3.75M Buy
1,101,680
+216,878
+25% +$782K 2.04% 14
2023
Q1 		$3.53M Hold
884,802
– – 1.72% 13
2022
Q4 		$4.81M Sell
884,802
-26,435
-3% -$156K 2.84% 6
2022
Q3 		$4.58M Buy
911,237
+286,424
+46% +$1.41M 2.81% 8
2022
Q2 		$2.74M Buy
624,813
+15,643
+3% +$99.9K 1.61% 18
2022
Q1 		$4.31M Buy
+609,170
New +$4.28M 1.99% 14

Other funds holding TGAN

Kohlberg Kravis Roberts & Co
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Carmignac Gestion
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Worth Venture Partners's TGAN Position: Q1 2024 in Review

Worth Venture Partners sold out of Transphorm, Inc. Common Stock (TGAN) in Q1 2024, closing a stake of 1,153,778 shares — an estimated $4.21M sold.

Worth Venture Partners first reported a position in TGAN in Q1 2022 and held it in 8 quarters. The position peaked at $4.81M in Q4 2022. 57 funds tracked by Wall St. Rank hold TGAN as of Q1 2024.

  • Worth Venture Partners reported no remaining Transphorm, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Worth Venture Partners sold 1,153,778 Transphorm, Inc. Common Stock shares in Q1 2024, an estimated $4.21M.
  • Worth Venture Partners first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Worth Venture Partners's Transphorm, Inc. Common Stock position peaked at $4.81M in Q4 2022.
  • 57 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.